The DOI matches its Crossref record.
Survival rates and patterns of care for patients diagnosed with supratentorial low‐grade gliomas: Data from the SEER program, 1973–2001
Open accessAbstract
BACKGROUND: Detailed population‐based estimates of long‐term survival as well as patterns of care for patients with low‐grade gliomas examined by age at diagnosis, gender, and race have not been widely available. METHODS: Time to death was examined among 2009 individuals diagnosed with a supratentorial low‐grade glioma and reported to the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute from 1973–2001 using Kaplan–Meier estimation. A Cox proportional hazards model was used to assess the effect of age at diagnosis, race, gender, histology, anatomic location within the brain, first course of treatment, and year of diagnosis upon this risk. RESULTS: The cumulative 5‐, 10‐, 15‐ and 20‐year survival rates among all individuals initially diagnosed with a supratentorial low‐grade glioma were 59.9% (95% confidence interval [95% CI], 57.6–62.2); 42.6% (95% CI, 39.9–45.2); 31.9% (95% CI, 29.0–34.8); and 26.0% (95% CI, 22.7–29.2), respectively. Improved survival was significantly associated with female gender (hazard ratio [HR], 0.84; 95% CI, 0.74–0.95), younger age, white race (HR, 0.70; 95% CI, 0.54–0.93), histology, and later year of diagnosis. Surgical treatment was associated with increased survival. The use of radiation therapy as a first course of treatment for these lesions has significantly decreased over time with the majority of patients receiving only surgery as a first course of treatment. CONCLUSIONS: Data for patients diagnosed with low‐grade gliomas revealed increasing survival times over the past 25 years with a subset of patients surviving for decades. Differences in survival by race, gender, histology, and first course of treatment were appreciated. These data suggested that the clinical course of low‐grade glioma for some patients may be more encouraging than previously perceived and that the identification of this group of patients may allow refinement of current treatment protocols. Cancer 2006. © 2006 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium
Bondy, M. L., Scheurer, M. E., Malmer, B., Barnholtz-Sloan, J. S., Davis, F. G., Il'yasova, D., Kruchko, C., McCarthy, B. J., Rajaraman, P., Schwartzbaum, J. A., et al. (2008) · Cancer · doi:10.1002/cncr.23741 · Cited by 932
Mutational landscape and clonal architecture in grade II and III gliomas
Suzuki, H., Aoki, K., Chiba, K., Sato, Y., Shiozawa, Y., Shiraishi, Y., Shimamura, T., Niida, A., Motomura, K., Ohka, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3273 · Cited by 831
Jakola, A. S., Myrmel, K. S., Kloster, R., Torp, S. H., Lindal, S., Unsgård, G., & Solheim, O. (2012) · JAMA · doi:10.1001/jama.2012.12807 · Cited by 641
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
Soffietti, R., Baumert, B. G., Bello, L., Von Deimling, A., Duffau, H., Frénay, M., Grisold, W., Grant, R., Graus, F., Hoang‐Xuan, K., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03151.x · Cited by 505
Survival and low-grade glioma: the emergence of genetic information
Claus, E. B., Walsh, K. M., Wiencke, J. K., Molinaro, A. M., Wiemels, J. L., Schildkraut, J. M., Bondy, M. L., Berger, M., Jenkins, R., & Wrensch, M. (2015) · Neurosurgical Focus · doi:10.3171/2014.10.focus12367 · Cited by 445
Self-citationOhgaki, H. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-492-0_14 · Cited by 418
Porter, K. R., McCarthy, B. J., Freels, S., Kim, Y., & Davis, F. G. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop066 · Cited by 342
Integrated genomic characterization of IDH1-mutant glioma malignant progression
Bai, H., Harmancı, A. S., Erson-Omay, E. Z., Li, J., Coşkun, S., Simon, M., Krischek, B., Özduman, K., Omay, S. B., Sorensen, E. A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3457 · Cited by 329
Surgical resection versus watchful waiting in low-grade gliomas
Jakola, A. S., Skjulsvik, A. J., Myrmel, K. S., Sjåvik, K., Unsgård, G., Torp, S. H., Aaberg, K., Berg, T., Dai, H. Y., Johnsen, K., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx230 · Cited by 306
Low-grade gliomas in adults: A review
Sanai, N., Chang, S., & Berger, M. S. (2011) · Journal of Neurosurgery · doi:10.3171/2011.7.jns101238 · Cited by 291
Molecular imaging of gliomas with PET: Opportunities and limitations
la Fougere, C., Suchorska, B., Bartenstein, P., Kreth, F.-W., & Tonn, J.-C. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor054 · Cited by 274
Awake Mapping Optimizes the Extent of Resection for Low-Grade Gliomas in Eloquent Areas
De Benedictis, A., Moritz-Gasser, S., & Duffau, H. (2010) · Neurosurgery · doi:10.1227/01.neu.0000369514.74284.78 · Cited by 252
Racial, ethnic and socioeconomic disparities in the treatment of brain tumors
Curry, W. T., & Barker, F. G. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9840-5 · Cited by 152
Little, M. P., Rajaraman, P., Curtis, R. E., Devesa, S. S., Inskip, P. D., Check, D. P., & Linet, M. S. (2012) · BMJ · doi:10.1136/bmj.e1147 · Cited by 110
Overview of prognostic factors in adult gliomas
Sharma, A., & Graber, J. J. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-20-640 · Cited by 70
Metadata
- Authors
- Claus, E. B., & Black, P. M.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2006-02-08
- Volume
- 106
- Issue
- 6
- Pages
- 1358-1363
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1488746701
- Cited by
- 226
- References
- 0
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.